Panels of genetic tests, genetic predispositions

Panels of genetic tests, genetic predispositions

Invicta logo

The PREGMED Non Public Clinic collaborates with
the Genetic Laboratory, which is a part of the INVICTA Medical Laboratories  (since 2001) and is a leader in complex DNA analyses. With its many-year experience, acquired both in Poland and at international centres, modern technologies and an innovative quality control system, it offers tests at very high sensitivity and reliability levels  An emphasis on top quality and reliability of results is the key standard of the INVICTA Laboratories.

The INVICTA Genetic Laboratory offers a broad range of molecular biology studies, including:

  • tests for predisposition to thromboembolic diseases
  • tests for predispositions to diseases of internal organs (kidneys, colon, stomach, lungs, ovaries, breasts, the prostate gland)
  • diagnostics towards genetically determined male and female infertility
  • genetic diagnostics of genitourinary tract infections
  • diagnostics of bacterial and viral infections plus many others.

The quality and reliability of tests, carried out at the INVICTA Laboratory, are confirmed by Polish and international certificates. The Laboratory’s activity is subject of regular, cyclic audits, while the knowledge and skills of its staff are verified by independent experts on current basis..

INVICTA’s patients obtain also an easy and quick access to test results and Rother important data via the INVICTA-ONLINE system.

Based on our collaboration with the INVICTA Genetic Laboratory, we offer state-of-the-art. genetic tests for genetic predispositions.  The tests are carried out on collected saliva samples, thus they are non-invasive and painless.

Test results are completed with risk assessment, prophylactic recommendations and practical indications, regarding appropriate style of life. The approximate waiting time for test results is 14 days.

See the table below for a list of proposed panels of genetic tests

Panel name

Tests in panel

Description

Type of material

Price (PLN)

Contraception

Detection of G20210A mutations in prothrombin gene (blood coagulation factor II)

Predispositions to thromboembolic diseases, induced by hormonal contraception

saliva

400

Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V)

Detection of polymorphism in MTHFR gene

Detection of mutations in BRCA-1 gene

Genetic

Detection of deletion in the AZF region

Predispositions to diseases and neoplasms

saliva

900

Detection of G20210A mutations in prothrombin gene (blood coagulation factor II)

Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V)

Detection of 2 mutations in CFTR gene

Detection of mutations in BRCA-1 gene

Detection of polymorphism in MTHFR gene

Detection of polymorphism in ACE gene

Detection of mutations in NOD2 gene

Detection of mutations in CHEK2 gene

Hormones

Detection  of  G20210A mutations in prothrombin gene (blood coagulation factor II)

Predispositions to thromboembolic diseases

saliva

400

Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V)

Detection of polymorphism in MTHFR gene

Detection of mutations in BRCA-1 gene

Male infertility

Detection of deletion in the AZF region

Underlying genetic defects of male infertility

saliva

200

Detection of 2 mutations in CFTR gene

Female infertility

Detection  of  G20210A mutations in prothrombin gene (blood coagulation factor II)

Underlying genetic defects of female infertility

saliva

400

Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V)

Detection of polymorphism in MTHFR gene

Detection of 2 mutations in CFTR gene

Neoplasms

Detection of mutations in BRCA-1 gene

Predispositions to neoplasms

saliva

300

Detection of mutations in NOD2 gene

Detection of mutations in CHEK2 gene

Breast and ovarian cancer

Detection of mutations w genie BRCA-1

Predispositions to breast and ovarian cancer

saliva

300

Detection of mutations in NOD2 gene

Detection of mutations in CHEK2 gene

Spontaneous abortions

Detection  of  G20210A mutations in prothrombin gene (blood coagulation factor II)

Predispositions to spontaneous abortions

saliva

300

Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V)

Detection of polymorphism in MTHFR gene

The heart

Detection  of  G20210A mutations in prothrombin gene (blood coagulation factor II)

Predispositions to thromboembolic diseases

saliva

300

Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V)

Detection of polymorphism in MTHFR gene

The heart and hypertension

Detection  of  G20210A mutations in prothrombin gene (blood coagulation factor II)

Predispositions to thromboembolic diseases and hypertension

saliva

400

Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V)

Detection of polymorphism in MTHFR gene

Detection of polymorphism in ACE gene

News
2014-08-05
The latest publication on cytomegaly
In June of 2014, the European Journal of Clinical Microbiology & Infectious Diseases published a report on cytomegaly in pregnant women.
2014-07-24
Colposcopy to be soon provided at NZOZ PREGMED
A diagnostic examination, identifying – among others – preclinical forms of uterine cervix malignancies, collection of targeted specimens, definition of surgery scope on the uterine cervix, the vagina or the vulva and evaluation of obtained ef
Read more news ...
Important
2013-12-13
There should be
Conventions and national and international conferences

Check our offer

PREGMED 93-355 ŁódĽ, al. 1 Maja 24/26, tel. 42 663 96 73, 606 355 606, e-mail: pregmed@pregmed.pl
Copyright © 2017 Pregmed - All rights reserved
Realization: Dianthus
Dokument wydrukowany ze strony: www.pregmed.pl/en/our-offer/laboratory-tests/panels-of-genetic-tests-genetic-predispositions/